Dr. Ganesh Iyer is a biotech leader with more than 20 years of experience in drug discovery and development, specializing in novel therapeutic approaches for complex diseases. As CEO and founder of Opprtna Therapeutics, a company pioneering innovative aptamer-based therapies, Dr. Iyer is dedicated to translating cutting-edge science into life-changing treatments. Dr. Iyer has advanced multiple targets from assay development through high-throughput screening campaigns, and he has led teams responsible for assays supporting targets in the central nervous system and cancer. He holds a PhD in biochemistry from Rensselaer Polytechnic Institute and an MS in chemistry from the Indian Institute of Technology (Mumbai). Dr. Iyer is a recognized leader in the field, with numerous scientific publications and presentations at international conferences. He is dedicated to advancing the field of aptamer therapeutics and bringing innovative solutions to patients who need them most.